PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban
Study sponsor: Artivion Inc. · AORT
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-12-12Actual
Enrollment · participants863Actual
Source updated2024-03-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.